Bishal Gyawali: Guidance for discussants of randomized cancer trials at major meetings
Bishal Gyawali, Associate Professor at Queen’s University, Kingston, shared a post on X about recent paper he and colleagues co-authored titled “Guidance for discussants of randomized cancer trials at major meetings” published on EJC.
Authors: Elizabeth A. Eisenhauer, Omar Abdihamid, Christopher M. Booth, Nathan Cherny, Antonio T. Fojo, Bishal Gyawali, Bernard L. Marinie, Ghulam Rehman Mohyuddin, Madeline Peg, Gregory R. Pond, Enrique Soto-Perez-de-Celis, Ian F. Tannock, Dario Trapani, Michelle Tregear, Winette T.A. van der Graaf, Brooke E. Wilson
“Ever been invited as a discussant to a plenary trial and wished you had a checklist to correctly and objectively appraise the clinical trial to enable the audience put things into correct perspective?
Well, Common Sense Oncology has just published a checklist to help you do just that!
We strongly encourage the conference organizers to ask the Discussants of major clinical trials to use this checklist for critical appraisal.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023